Unilife Corporation Stock Skyrockets On Contractual Agreement (NASDAQ:UNIS)

Unilife Corporation (NASDAQ:UNIS)

As the global generic injectable drugs market scales over $120 billion, take a look at Unilife Corporation ticker symbol UNIS. Unilife Corporation is a United States based developer and commercial supplier of injectable drug delivery systems. This Company has currently surged +43.29% Up 1.21 with over 6.6 million shares in play Wednesday November 20, 2013 11:32AM EST. What makes this Company (www.unilife.com) hot in today’s stock market is Unifill®.

The Unifill® platform, is the world’s 1st  known platform of prefilled syringes with automatic and fully integrated needle retraction. Today, Unilife Corporation announced that they have signed a long-term supply contract with Hikma Pharmaceuticals to boost up delivery of  their generic injectables. This is huge when you consider the fact that the Company will begin product sales to Hikma Pharmaceuticals  in 2014. Hikma Pharmaceuticals will pay Unilife Corporation $40 million in upfront and milestone payments, and need we not forget to mention the $5 million they already received. The 15 year supply agreement  involves 20 generic injectable drugs within the The Unifill® platform. While we’re on the subject of 15, let’s keep in mind the $15 million that Unilife Corporation expects to recieve in 2014. To view the Unifill® platform visit URL (http://www.unilife.com/product-platforms/prefilled-syringes/unifill-syringe) via the web.

****

Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT)

While we’re on the subject of medical treatment, let’s check out Oxygen Biotherapeutics ticker symbol OXBT.  Oxygen Biotherapeutics specializes in oxygen-carrying therapeutics. This Company (www.oxybiomed.com) has currently surged +25.14% Up 1.33 with over 3.5 million shares in play Wednesday November 20, 2013 12:05PM EST. What makes this a hot topic in wall street today, is investors are wondering if the stock has bottomed out. 

While the bears prospect if the stock is experiencing  a dead count bounce, the bulls understand it has more bounce than the ounce. In fact, if we where playing poker this play could potentially be considered as a chip up. Remember, Oxygen Biotherapeutics has improved their earnings per share this recent quarter when compared to the same quarter a year prior. Positive earning with most investors trigger an entrance.

Remember: Always do your homework and consult your own financial professional.

Read Full Disclaimer at http://crweselect.com/disclaimer/